Kostos L, Buteau JP, Xie J, Cardin A, et al. Lutetium-177 [(177)Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial. Lancet Oncol 2025 Oct 18:S1470-2045(25)00559.
PMID: 41119954